SGMC Health Offers New Treatment Option for Early Alzheimer’s Disease

SGMC Health now offers an FDA-approved treatment option for people in the early stages of Alzheimer's disease, giving patients and families in South Georgia access to care that can help slow the disease's progression.

The anti-amyloid infusion therapy is available through SGMC Neurology for individuals with mild memory or thinking problems caused by Alzheimer's disease. It is one of the first treatments designed to slow the disease itself, rather than only easing symptoms.

The therapy is given through regularly scheduled IV infusions and works by helping the body remove substances in the brain that are believed to contribute to Alzheimer's disease. When used early, these treatments may help people keep their independence and daily routines longer.

"This is an important step forward for patients who are just beginning to experience changes in memory or thinking," said Mahmood Eisa, MD, neurologist at SGMC Health. "While this treatment does not cure Alzheimer's or restore lost memories, it can slow how quickly the disease progresses for some patients, which can make a meaningful difference for both individuals and their families."

This treatment is not for everyone and is intended only for people in the earliest stages of Alzheimer's disease. Before starting therapy, patients must complete several evaluations to make sure the treatment is appropriate and safe.

In general, patients may qualify if they:

• Are experiencing early memory or thinking changes linked to Alzheimer's disease
• Complete testing that confirms these changes
• Are able to attend regular infusion visits and follow-up appointments

A neurology provider works closely with patients and caregivers to review results and help them decide whether this option is right for them.

"Our team takes time to educate patients and families, answer questions, and monitor closely every step of the way," Dr. Eisa said. "This is very much a shared decision, and we want people to feel informed and supported."

These treatments work best when Alzheimer's disease is identified early. Patients or family members who notice changes in memory, decision-making, or daily functioning are encouraged to talk with their provider or call SGMC Neurology at 229-242-1234.